DONALD YEE to Neoplasm Recurrence, Local
This is a "connection" page, showing publications DONALD YEE has written about Neoplasm Recurrence, Local.
Connection Strength
0.032
-
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood Adv. 2023 10 24; 7(20):6055-6065.
Score: 0.032